These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38389986)

  • 1. Abstinence duration and psychopathology among addiction outpatients during 18 months of COVID-19.
    Daigre C; Palma-Álvarez RF; Sorribes-Puertas M; Ortega-Hernández G; Perea-Ortueta M; Ros-Cucurull E; Segura L; Colom J; Braquehais MD; Ramos-Quiroga JA; Grau-López L
    Front Psychiatry; 2024; 15():1339730. PubMed ID: 38389986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Multicenter Study on the Impact of Gender, Age, and Dual Diagnosis on Substance Consumption and Mental Health Status in Outpatients Treated for Substance Use Disorders During COVID-19 Lockdown.
    Daigre C; Grau-López L; Palma-Alvarez RF; Perea-Ortueta M; Sorribes-Puertas M; Serrano-Pérez P; Quesada M; Segura L; Coronado M; Ramos-Quiroga JA; Colom J;
    J Dual Diagn; 2022; 18(2):71-80. PubMed ID: 35324373
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment retention and abstinence of patients with substance use disorders according to addiction severity and psychiatry comorbidity: A six-month follow-up study in an outpatient unit.
    Daigre C; Rodríguez L; Roncero C; Palma-Álvarez RF; Perea-Ortueta M; Sorribes-Puertas M; Martínez-Luna N; Ros-Cucurull E; Ramos-Quiroga JA; Grau-López L
    Addict Behav; 2021 Jun; 117():106832. PubMed ID: 33529849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Lockdown and Consumption Patterns among Substance Use Disorder Outpatients: A Multicentre Study.
    Grau-López L; Daigre C; Palma-Alvarez RF; Sorribes-Puertas M; Serrano-Pérez P; Quesada-Franco M; Segura L; Coronado M; Ramos-Quiroga JA; Colom J;
    Eur Addict Res; 2022; 28(4):243-254. PubMed ID: 35038702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of COVID-19 lockdown on individuals under treatment for substance use disorders: Risk factors for adverse mental health outcomes.
    Blithikioti C; Nuño L; Paniello B; Gual A; Miquel L
    J Psychiatr Res; 2021 Jul; 139():47-53. PubMed ID: 34029833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment staff's continuity of care practices, patients' engagement in continuing care, and abstinence following outpatient substance-use disorder treatment.
    Schaefer JA; Harris AH; Cronkite RC; Turrubiartes P
    J Stud Alcohol Drugs; 2008 Sep; 69(5):747-56. PubMed ID: 18781250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance use during the COVID-19 pandemic: What is really happening?
    Mellos E; Paparrigopoulos T
    Psychiatriki; 2022 Mar; 33(1):17-20. PubMed ID: 35255473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian Rhythmic Characteristics in Men With Substance Use Disorder Under Treatment. Influence of Age of Onset of Substance Use and Duration of Abstinence.
    Capella MDM; Martinez-Nicolas A; Adan A
    Front Psychiatry; 2018; 9():373. PubMed ID: 30174624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the relationship of COVID-19 related stress and media consumption with schizotypy, depression, and anxiety in cross-sectional surveys repeated throughout the pandemic in Germany and the UK.
    Daimer S; Mihatsch LL; Neufeld SAS; Murray GK; Knolle F
    Elife; 2022 Jul; 11():. PubMed ID: 35781372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personality change during substance use disorder treatment is associated with improvements in abstinence self-efficacy post-treatment among U.S. military veterans.
    Blonigen DM; Macia KS
    J Subst Abuse Treat; 2021 Jan; 120():108187. PubMed ID: 33298306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential relationships between continuity of care practices, engagement in continuing care, and abstinence among subgroups of patients with substance use and psychiatric disorders.
    Schaefer JA; Cronkite RC; Hu KU
    J Stud Alcohol Drugs; 2011 Jul; 72(4):611-21. PubMed ID: 21683043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress, Personality, Attachment, and Coping Strategies During the COVID-19 Pandemic: The STERACOVID Prospective Cohort Study Protocol.
    Edjolo A; Dorey JM; Herrmann M; Perrot C; Lebrun-Givois C; Buisson A; El Haouari H; Laurent B; Pongan E; Rouch I
    Front Psychiatry; 2022; 13():918428. PubMed ID: 35832598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopathological Burden and Quality of Life in Substance Users During the COVID-19 Lockdown Period in Italy.
    Martinotti G; Alessi MC; Di Natale C; Sociali A; Ceci F; Lucidi L; Picutti E; Di Carlo F; Corbo M; Vellante F; Fiori F; Tourjansky G; Catalano G; Carenti ML; Incerti CC; Bartoletti L; Barlati S; Romeo VM; Verrastro V; De Giorgio F; Valchera A; Sepede G; Casella P; Pettorruso M; di Giannantonio M
    Front Psychiatry; 2020; 11():572245. PubMed ID: 33101086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of Treatment Outcome, Follow-Up, and Abstinence Rates Among Patients With Alcohol Use Disorder: A Prospective Study.
    Gc M; Sankaran A; Subramanian K; Subramanian E
    Cureus; 2022 Nov; 14(11):e31356. PubMed ID: 36514662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remotely Assessing Mechanisms of Behavioral Change in Community Substance Use Disorder Treatment to Facilitate Measurement-Informed Care: Pilot Longitudinal Questionnaire Study.
    Hallgren KA
    JMIR Form Res; 2022 Nov; 6(11):e42376. PubMed ID: 36342773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A scoping review of electroencephalographic (EEG) markers for tracking neurophysiological changes and predicting outcomes in substance use disorder treatment.
    Bel-Bahar TS; Khan AA; Shaik RB; Parvaz MA
    Front Hum Neurosci; 2022; 16():995534. PubMed ID: 36325430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbid mental disorders in substance users from a single catchment area--a clinical study.
    Langås AM; Malt UF; Opjordsmoen S
    BMC Psychiatry; 2011 Feb; 11():25. PubMed ID: 21314980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates and Correlates of Alcohol and Substance Use Among Women Veterans During the COVID-19 Pandemic: The Moderating Role of COVID-Specific Anxiety.
    Buckheit KA; Pengelly C; Ramon A; Guyker W; Cook-Cottone C; King PR
    Womens Health Issues; 2023; 33(3):250-257. PubMed ID: 37003919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.